BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17934839)

  • 1. Meta-analysis of the placebo response in ulcerative colitis.
    Garud S; Brown A; Cheifetz A; Levitan EB; Kelly CP
    Dig Dis Sci; 2008 Apr; 53(4):875-91. PubMed ID: 17934839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
    Jairath V; Zou G; Parker CE; Macdonald JK; Mosli MH; Khanna R; Shackelton LM; Vandervoort MK; AlAmeel T; Al Beshir M; AlMadi M; Al-Taweel T; Atkinson NS; Biswas S; Chapman TP; Dulai PS; Glaire MA; Hoekman D; Koutsoumpas A; Minas E; Samaan MA; Travis S; D'Haens G; Levesque BG; Sandborn WJ; Feagan BG
    J Crohns Colitis; 2016 May; 10(5):607-18. PubMed ID: 26746169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis.
    Su C; Lewis JD; Goldberg B; Brensinger C; Lichtenstein GR
    Gastroenterology; 2007 Feb; 132(2):516-26. PubMed ID: 17258720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis.
    Ma C; Guizzetti L; Panaccione R; Fedorak RN; Pai RK; Parker CE; Nguyen TM; Khanna R; Vande Casteele N; D'Haens G; Sandborn WJ; Feagan BG; Jairath V
    Aliment Pharmacol Ther; 2018 Jun; 47(12):1578-1596. PubMed ID: 29696670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting clinical and endoscopic remission with placebo therapy in East Asian patients with ulcerative colitis: a systematic review and meta-analysis.
    Zeng J; Wang Z; Yang XJ
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1069-1077. PubMed ID: 35347342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis.
    Youssef M; Dong K; Lee SJ; Narula N
    Inflamm Bowel Dis; 2024 Jan; 30(1):125-131. PubMed ID: 36753516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics for maintenance of remission in ulcerative colitis.
    Naidoo K; Gordon M; Fagbemi AO; Thomas AG; Akobeng AK
    Cochrane Database Syst Rev; 2011 Dec; (12):CD007443. PubMed ID: 22161412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics for induction of remission in ulcerative colitis.
    Kaur L; Gordon M; Baines PA; Iheozor-Ejiofor Z; Sinopoulou V; Akobeng AK
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD005573. PubMed ID: 32128795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vedolizumab for induction and maintenance of remission in ulcerative colitis.
    Bickston SJ; Behm BW; Tsoulis DJ; Cheng J; MacDonald JK; Khanna R; Feagan BG
    Cochrane Database Syst Rev; 2014 Aug; (8):CD007571. PubMed ID: 25105240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics for maintenance of remission in ulcerative colitis.
    Iheozor-Ejiofor Z; Kaur L; Gordon M; Baines PA; Sinopoulou V; Akobeng AK
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD007443. PubMed ID: 32128794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal nicotine for induction of remission in ulcerative colitis.
    McGrath J; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004722. PubMed ID: 15495126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-Analysis.
    Magro F; Estevinho MM; Dias CC; Correia L; Lago P; Ministro P; Portela F; Feakins R; Danese S; Peyrin-Biroulet L
    J Crohns Colitis; 2021 Apr; 15(4):551-566. PubMed ID: 32898223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of the placebo response in ulcerative colitis.
    Ilnyckyj A; Shanahan F; Anton PA; Cheang M; Bernstein CN
    Gastroenterology; 1997 Jun; 112(6):1854-8. PubMed ID: 9178676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK; Wang JJ
    Cochrane Database Syst Rev; 2010 Oct; (10):CD006774. PubMed ID: 20927749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.
    Costello SP; Soo W; Bryant RV; Jairath V; Hart AL; Andrews JM
    Aliment Pharmacol Ther; 2017 Aug; 46(3):213-224. PubMed ID: 28612983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.
    Ford AC; Achkar JP; Khan KJ; Kane SV; Talley NJ; Marshall JK; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):601-16. PubMed ID: 21407188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo Rates in Randomized Controlled Trials of Pouchitis Therapy.
    Athayde J; Davies SC; Parker CE; Guizzetti L; Ma C; Khanna R; Feagan BG; Jairath V
    Dig Dis Sci; 2018 Oct; 63(10):2519-2528. PubMed ID: 29995184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.